Rostislav Novak

Rostislav Novak

Auto-generated profile, based on publicly available information

Rostislav Novak

Musculoskeletal Oncology Surgery, Rambam Health Care Campus, Haifa, Israel

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in International Endodontic Journal
Verified
Journal Article
Open access
Shaul LinShaul Lin
Shaul Lin
AMAthina M. Mavridou
Athina M. Mavridou
RNRostislav Novak
Rostislav Novak
DMDaniel Moreinos
Daniel Moreinos
PAPaul Abbott
Paul Abbott
IRIlan Rotstein
Ilan Rotstein
Background: The mechanism of action of root resorption in a permanent tooth can be classified as infection‐related (e.g., microbial infection) or non‐infection‐related (e.g., sterile damage). Infection induced root resorption occurs due to bacterial invasion. Non‐infection‐related root resorption stimulates the immune system through a different mechanism.Objectives: The aim of this narrative review is to describe the pathophysiologic process of non‐infection‐related inflammatory processes involved in root resorption of permanent teeth.Methods: A literature search on root resorption was conducted using Scopus (PubMed and Medline) and Google Scholar databases to highlight the pathophysiology of bone and root resorption in non‐infection‐related situations. The search included key words covering the relevant category. It included in vitro and in vivo studies, systematic reviews, case series, reviews, and textbooks in English. Conference proceedings, lectures and letters to the editor were excluded.Results: Three types of root resorption are related to the non‐infection mechanism of action, which includes surface resorption due to either trauma or excessive orthodontic forces, external replacement resorption and external cervical resorption. The triggers are usually damage associated molecular patterns and hypoxia conditions. During this phase macrophages and clastic cells act to eliminate the damaged tissue and bone, eventually enabling root resorption and bone repair as part of wound healing.Discussion: The resorption of the root occurs during the inflammatory phase of wound healing. In this phase, damaged tissues are recognized by macrophages and neutrophiles that secrete interlaukines such as TNF‐α, IL‐1, IL‐6, IL‐8. Together with the hypoxia condition that accelarates the secretion of growth factors, the repair of the damaged perioduntiom, including damaged bone, is initiated. If the precementum and cementoblast are injured, root resorption can occur.Conclusions: Wound healing exhibits different patterns of action that involves immune stimulation in a bio‐physiological activity, that occurs in the proper sequence, with overlapping phases. Two pathologic conditions, DAMPs and hypoxia, can activate the immune cells including clastic cells, eliminating damaged tissue and bone. Under certain conditions, root resorption occurs as a side effect.

24 September 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RNRostislav Novak
Rostislav Novak
YAYamen Abu Ahmad
Yamen Abu Ahmad
MTMichael Timaner
Michael Timaner
EBEliya Bitman-Lotan
Eliya Bitman-Lotan
AOAvital Oknin-Vaisman
Avital Oknin-Vaisman
Amir OrianAmir Orian
Amir Orian
Molecular understanding of osteogenic differentiation (OD) of human bone marrow-derived mesenchymal stem cells (hBMSCs) is important for regenerative medicine and has direct implications for cancer. We report that the RNF4 ubiquitin ligase is essential for OD of hBMSCs, and that RNF4-deficient hBMSCs remain as stalled progenitors. Remarkably, incubation of RNF4-deficient hBMSCs in conditioned media of differentiating hBMSCs restored OD. Transcriptional analysis of RNF4-dependent gene signatures identified two secreted factors that act downstream of RNF4 promoting OD: (1) BMP6 and (2) the BMP6 co-receptor, RGMb (Dragon). Indeed, knockdown of either RGMb or BMP6 in hBMSCs halted OD, while only the combined co-addition of purified RGMb and BMP6 proteins to RNF4-deficient hBMSCs fully restored OD. Moreover, we found that the RNF4-RGMb-BMP6 axis is essential for survival and tumorigenicity of osteosarcoma and therapy-resistant melanoma cells. Importantly, patient-derived sarcomas such as osteosarcoma, Ewing sarcoma, liposarcomas, and leiomyosarcomas exhibit high levels of RNF4 and BMP6, which are associated with reduced patient survival. Overall, we discovered that the RNF4~BMP6~RGMb axis is required for both OD and tumorigenesis.

5 May 2023 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PRP. D. Rowell
P. D. Rowell
PFP. C. Ferguson
P. C. Ferguson
KTKim Tsoi
Kim Tsoi
JNJ. L. Nevin
J. L. Nevin
RNR. Novak
R. Novak
JWJay S Wunder
Jay S Wunder

18 September 2024 in International Endodontic Journal
Verified
Journal Article
Open access
Shaul LinShaul Lin
Shaul Lin
DMD. Moreinos
D. Moreinos
AMA. M. Mavridou
A. M. Mavridou
RNR. Novak
R. Novak
IRI. Rotstein
I. Rotstein
PAPaul Abbott
Paul Abbott
Background: Root resorption consists of complex, multistep processes that involve cell signalling caused by inflammation and stromal cells, which promotes the secretion of receptor activator of nuclear factor κB ligand/ macrophage‐colony stimulating factor (RANKL/M‐CSF) resulting in a resorptive process.Objective: The aim of this narrative review was to analyse the literature related to root resorption resulting from microbial infection and to comparing it with non‐microbial infection.Methods: An electronic literature search was performed using the PubMed database and applying keywords of articles published in English. Eligible papers were reviewed to reveal the descriptions of bone and root resorption processes. The abstracts were searched manually to identify articles about infection‐stimulating bone and root resorption.Results: Three main types of root resorption were identified, two associated with primary bacterial infection and one secondary to bacterial infection. These include external inflammatory resorption, internal inflammatory resorption and external cervical (invasive) resorption.Discussion: The magnitude of cytokine involvement that promotes resorption and M‐CSF/RANKL production depends on multiple factors, including pathogen virulence, site of infection and host genetic factors that activate the inflammation at the infection site. Two mechanisms activate the resorption mechanisms—the canonical and non‐canonical pathways that can activate clastic cells independently of the RANKL/RANK canonical pathways.Conclusions: Two pathways of root resorption co‐exist in the body. When resorption is caused by infection, chronic inflammation due to bacterial infection prolongs the secretions of pro‐inflammatory cytokines that intensify root and bone resorption. The second pathway is bacterial independent of the non‐infection root resorption that is part of the wound healing process, which is limited in time due to its innate ability.

20 July 2012 in Rambam Maimonides Medical Journal
Verified
Journal Article
Open access
JFJ. Daniel Freedman
J. Daniel Freedman
RNRostislav Novak
Rostislav Novak
SMSharon Bratman Morag
Sharon Bratman Morag
EAEmily Avitan-Hersh
Emily Avitan-Hersh
DNDavid Nikomarov
David Nikomarov
Mutations in FGF23, KL, and GALNT3 have been identified as the cause for the development of hyperphosphatemic familial tumoral calcinosis (HFTC). Patients with HFTC typically present in childhood or adolescence with periarticular soft tissue deposits that eventually progress to disrupt normal joint articulation. Mutations in the GALNT3 gene were shown to account for the hyperphosphatemic state in both HFTC and hyperostosis-hyperphosphatemia syndrome (HHS), the latter characterized by bone involvement. We present the case of a patient of a Druze ethnic origin with known HFTC that presented to our department with the first documented case of pathologic fracture occurring secondary to the disease. Our report introduces this new phenotypic presentation, suggests a potential role for prophylactic bone screening, and highlights the need for preconception genetic screening in selected populations.

14 November 2025 in Surgical Neurology International
Verified
Journal Article
Open access
SGSegev Gabay
Segev Gabay
MSMarga Serafimova
Marga Serafimova
RNRostislav Novak
Rostislav Novak
DNDavid Nikomarov
David Nikomarov
EVEuvgeni Vlodavsky
Euvgeni Vlodavsky
YSYuval Shapira
Yuval Shapira
Background: Meningioma is the most common primary intracranial tumor. Less commonly, it may also arise extracranially in ectopic locations. Primary ectopic meningioma arising from the brachial plexus is extremely rare, with only two published cases. We present a case of primary brachial plexus meningioma, proven by histological analysis, and a review of the literature. Case Description: A 25-year-old man presented with swelling in the left supraclavicular region. Magnetic resonance imaging (MRI) demonstrated the presence of a mass arising from the brachial plexus. Initial pathological diagnosis and repeat biopsies were inconclusive and interpreted as a low-grade mesenchymal tumor with uncertain biologic potential. The proposed differential diagnosis included epithelioid schwannoma, atypical epithelioid neoplasm, or a low-grade malignancy. The fact that the differential diagnosis included both benign possibilities and low-grade malignancies raised complex questions about the preferred treatment plan. The surgical techniques necessary for each of these diagnoses vary. Typically, soft-tissue malignancies necessitate extensive resection, while in benign tumors, limited resection may suffice. Extensive resection within the brachial plexus carries substantial neurological and, therefore, functional morbidity. Finally, the patient underwent marginal resection of the tumor. The final pathological diagnosis was concluded as meningioma. The patient recovered completely, without neurological deficits, and repeated MRI demonstrated no residual or recurrence of the lesion. Conclusion: Although uncommon, we recommend considering the rare possibility of meningioma as a differential diagnosis for brachial plexus tumors, particularly in cases where the initial pathological examination is inconclusive for more prevalent tumors such as schwannoma and neurofibroma. Due to the rarity of this pathology, conclusive treatment recommendations cannot be made, especially regarding the decision to follow-up versus surgical resection. This debate is particularly pertinent in instances where the malignant potential of the pathology is uncertain and where surgical intervention carries a significant risk of functional impairment. We believe that maximal and safe surgical excision is the primary method of treatment, which potentially confers an excellent prognosis.